U.K. DRUG FOR ABUSE TESTING DEVICES MARKET ANALYSIS

U.K. Drug for Abuse Testing Devices Market, by Product Type (Immunoassay Analyzers, Chromatography Instruments, Breathalyzers (Semiconductor-based Breathalyzer, Infrared (IR) Based Breathalyzer, and Fuel Cell-based Breathalyzer), Oral Fluid Testing Devices, Urine Testing Devices (Drug Testing Cup, DIP Cards, and Drug Testing Cassettes) , and Consumables (Assay Kits, Calibrators and Controls, and Others)), by Sample Type (Urine, Breathe, Saliva, Hair, and Others), and by End User (Hospitals, Federal Departments, Rehabilitation Centers, Diagnostic Laboratories, Academic Institutes and Research Centers, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : May 2021
Code : CMI4439
Pages :185
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key Players

Major players operating in the U.K. drug for abuse testing devices market include Abbott Laboratories, Thermo Fisher Scientific, Inc, Drägerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics, Alfa Scientific Designs, Inc, Lifeloc Technologies Inc, Lion Laboratories Limited, OraSure Technologies, Inc, Omega Laboratories, Inc., Shimadzu Corporation, Siemens Healthineers, F. Hoffmann-La Roche AG, Premier Biotech, Inc, Psychemedics Corporation, Innovative Testing Solutions, Biopanda Reagents Ltd, Alpha Laboratories, Matrix Diagnostics, Atlas Medical, Rapid Labs Limited, and Randox Laboratories Ltd.